CD44 and pulmonary fibrosis: Although similarly Li et al. showed that fibroblasts isolated from bleomycin-treated CD44-null mice or from WT-mice treated with CD44 mAb, impair invasive capacity, their CD44-null mice are not protected from pulmonary fibrosis and lack tissue regeneration [33].